Synthesis of compound 2
Scheme 1: Synthesis of compound 2. a) Et3N, toluene, reflux, 4 h, 81%. b) TCCA (1 eq), TEMPO, CH2Cl2, RT, 30 min., 58%. c) DBBA (0.6 eq), ACN, reflux, 4 h, 73%. d) 2,4-diaminopyrimidinone (1 eq), NaOAc (2 eq), H2O/ACN, 40°C, 4 h, 58%. e) H2NNH2 (10 eq), EtOH, reflux, overnight, TFA (1%),
RT, overnight, 83%.
N-(5-Hydroxypentyl)phthalimide
Aminopentanol (2.820 g, 27.3 mmol) was dissolved in tolune (41 ml) and phthalic anhydride (4.049 g, 27.3 mmol) and triethylamine (273 mg, 2.7 mmol) were added. The reaction mixture was heated to 130°C and refluxed for 4 hours. The solvents were evaporated, and the oily residue was dissolved in ethyl acetate. The organic phase was washed with 1 M HCl, saturated NaHCO3 and saturated NaCl, dried over Na2SO4 and evaporated. 
N-(5-Oxopentyl)phthalimide
5-Hydroxypentylphthalimide (1.195 g, 5.12 mmol) was dissolved in dry dichloromethane (15 ml) and cooled to 0°C in an ice bath. Trichloroisocyanuric acid (1.190 g, 5.12 mmol) and 2,2,6,6-tetramethylpiperidinyloxyl (TEMPO) (8 mg, 0.0512 mmol) were added and a yellow suspension was formed. The reaction mixture was stirred at room temperature for 30 minutes and was then filtered through a celite pad. The organic phase was washed with saturated NaHCO3, 1 M HCl and saturated NaCl, dried over Na2SO4, evaporated and dried under high vacuum. 
N-(4-Bromo-5-oxopentyl)phthalimide
N- (5-oxopentyl) phthalimide (400 mg, 1.73 mmol) was dissolved in acetonitrile (5 ml) and 5,5-dibromobarbituric acid (297 mg, 1.03 mmol) was added. The solution was refluxed for 4
hours, cooled to room temperature and evaporated. The crude product was purified by column chromatography on silica gel (ethylacetate/cyclohexane, 2:8 -3:7). 
Yield

7-(3-Aminopropyl)-7-deazaguanine trifluoroacetate 2
7-(3-Phthalimidopropyl)-7-deazaguanine (230 mg, 0.68 mmol) was dissolved in ethanol and hydrazine monohydrate (64%, 341 mg, 6.8 mmol) was added dropwise. The reaction mixture was refluxed overnight, the solvents were evaporated, and the crude product was dried under high vacuum. It was then suspended in trifluoroacetic acid (1%, 6 ml) and was shaken overnight at room temperature. The insoluble residue was filtered off and the filtrate was concentrated in vacuo. The crude product was purified by reversed phase chromatography on an ÄKTA prime plus system (LiChroprep® RP-18 (40 -63 µm), 1% trifluoroacetic acid/acetonitrile, 100:0 -70:30, 360 ml, flow rate 4 ml/min). 
Yield
Synthesis of compound 3 3
Scheme 2: Synthesis of compound 3. a) preQ1 (1.2 eq), (CH3)4NHB(OAc)3 (2.5 eq), HOAc, DMF, RT, 5 h, 96%. b) H2NNH2 (10 eq), EtOH, reflux, overnight, TFA (1%), RT, overnight, 77%.
7-((Phthalimidopropyl)aminomethyl)-7-deazaguanine
PreQ1 (387 mg, 1.32 mmol) was dissolved in dimethylformamide (15 ml) and N- (3- 
Synthesis of compound 4
Scheme 3: Synthesis of compound 4. a) Pd/C (10wt%), H2, MeOH, RT, 3.5 h, 63%.
7-((4-Aminobutyl)aminomethyl)-7-deazaguanine trifluoroacetate 4
Azidobutyl-preQ1 trifluroacetate (65 mg, 0.167 mmol) was dissolved in methanol (1.5 ml) and palladium on carbon (7.6 mg, loading 10wt%) was added. The suspension was stirred at room temperature and hydrogen in a balloon was bubbled through for half an hour. Afterwards the suspension was stirred under hydrogen atmosphere for 3 hours, diluted with methanol and filtered through a celite pad. The solution was concentrated in vacuo and the crude product was purified by reversed phase chromatography on an ÄKTA prime plus system (LiChroprep® RP-18 (40 -63 µm), 1% trifluoroacetic acid/acetonitrile, 95:5, flow rate 3 ml/min). 
Synthesis of compound 5
Scheme 4: Synthesis of compound 5. a) NaN3 (3 eq), DMF, 65°C, 22 h, 83%. b) Dess-Martin periodinane (1.3 eq), CH2Cl2, RT, 1 h, 92%. c) preQ1 (1.1 eq), (CH3)4NHB(OAc)3 (2 eq), HOAc, DMF,
RT, 5 h, 47%.
3-Azidopropanol
Sodium azide (4.68 g, 72 mmol) was suspended in dimethylformamide (16 m) and 3-chloropropanol (2 ml, 24 mmol) was added. The suspension was stirred under argon atmosphere for 22 hours at 65°C. After cooling to room temperature, the mixture was diluted with water, extracted with diethyl ether, washed with saturated NaHCO3 and NaCl, dried over 
3-Azidopropanal
3-Azidopropanol (200 mg, 2.0 mmol) was dissolved in dry dichloromethane (20 ml) and DessMartin periodinane (1.10 g, 2.6 mmol) was added in portions. The reaction mixture was stirred for 1 hour at room temperature under argon atmosphere. Subsequently, the suspension was filtered through a celite pad and the filtrate was concentrated in vacuo. The crude product was purified by column chromatography on silica gel (pentane/diethyl ether, 75:25). 
Synthesis of compound 6
Scheme 5: Synthesis of compound 6. a) NaI (1 eq), benzoyl chloride (1 eq), ACN, RT, overnight, 90%.
b) NaN3 (1.5 eq), DMF, 0°C -RT, overnight, quantitative. c) LiOH (1.2 eq), THF/H2O/MeOH (10/4/1.1),
RT, overnight, 95%. d) Dess-Martin periodinane (1.3 eq), CH2Cl2, RT, 1 h, 86%. e) preQ1 (1.1 eq), (CH3)4NHB(OAc)3 (3.1 eq), HOAc, DMF, RT, 5 h, 46%.
4-Iodobutyl benzoate 1
To a cooled solution of sodium iodide (18.4 g, 123 mmol) in tetrahydrofuran (10 ml, 123 mmol) and acetonitrile (5 ml), benzoyl chloride (14.8 ml, 123 mmol) was added in one portion. The reaction mixture was stirred in the dark overnight. After dilution of the reaction mixture with water and ether, the organic layers were separated and the aqueous layer was extracted three times with ether. The combined organic layers were washed with saturated NaHSO3, Na2CO3
and dried over MgSO4. The solvent was removed in vacuo to give the product as colorless oil.
Yield: 33.7 g (90%) colorless oil 
4-Azidobutanol 1
Lithium hydroxide (3.10 g, 74 mmol) was added to a solution of 4-azidobutyl benzoate (13.5 g, 61.6 mmol) in tetrahydrofuran (40 ml), water (16 ml) and methanol (4.4 ml). The reaction mixture was stirred overnight and subsequently diluted with water and ether. The layers were separated and the aqueous layer was further extracted with ether three times. The combined organic layers were washed with saturated NaCl and dried over MgSO4. The solvent was removed in vacuo to give the product as yellow oil. 
4-Azidobutanal
4-Azidobutanol (830 mg, 7.20 mmol) was dissolved in dry CH2Cl2 (70 ml) and Dess-Martin periodinane (3.97 g, 9.36 mmol) was added. The white suspension was stirred at room temperature under argon atmosphere. After 1 hour the mixture was diluted with dichloromethane, washed with saturated Na2S2O3, NaHCO3 and NaCl, dried over Na2SO4 and concentrated in vacuo. The crude product was purified by column chromatography on silica gel (diethyl ether/hexane, 25:75). 
Synthesis of compound 7
Scheme 6: Synthesis of compound 7. a) NaN3 (2 eq), H2O, reflux, 21 h, 98%. b) Dess-Martin periodinane (1.3 eq), CH2Cl2, RT, 1 h, 88%. c) preQ1 (1.1 eq), (CH3)4NHB(OAc)3 (1.5 eq), HOAc, DMF, RT, 5 h, 37%.
2-(2-Azidoethoxy)ethanol
2-(2-Chloroethoxy)ethanol (8.47 ml, 80 mmol) was dissolved in ater (34 ml) and sodium azide 
2-(2-Azidoethoxy)acetaldehyde
2-(2-Azidoethoxy)ethanol (337 mg, 2.57 mmol) was dissolved in dichloromethane (50 ml) and 
Synthesis of compound 8
Scheme 7: Synthesis of compound 8. a) Dess-Martin periodinane (1.15 eq), CH2Cl2, RT, 3 h, 73%. b) preQ1 (1.1 eq), (CH3)4NHB(OAc)3 (1.9 eq), HOAc, DMF, RT, 5 h, 21%.
2-(2-(2-Methoxyethoxy)ethoxy)acetaldehyde
Dess-Martin periodinane (1000 mg, 2.35 mmol)was suspended in dry dichloromethane (20 ml) and triethylene glycol monomethyl ether (336 mg, 2.05 mmol) was added. The suspension was stirred at room temperature for 3 hours, filtered through a celite pad and evaporated. 
7-(5,8,11-trioxa-2-azadodecyl)-7-deazaguanine trifluoroacetate 8
2-(2-(2-Methoxyethoxy)ethoxy)acetaldehyde (22 mg, 0.136 mmol) was dissolved in dry dimethylformamide (1 ml) and stirred at room temperature. Then, tetramethylammonium triacetoxyborohydride (66 mg, 0.253 mmol) and acetic acid (7 µl) were added successively.
PreQ1 trifluoroacetate (43 mg, 0.146 mmol) was dissolved in dry dimethylformamide (1 ml) and was added dropwise to the reaction mixture. The solvents were evaporated after 5 hours and the crude product was purified by reversed phase column chromatography on an ÄKTA prime plus system (LiChroprep® RP-18 (40 -63 µm), 1% trifluoroacetic acid/acetonitrile, 100:0 -70:30, 360 ml, flow rate 4 ml/min). 
Yield
Synthesis of compound 9
Scheme 8: Synthesis of compound 9. a) glutaraldehyde (0.8 eq, 50wt%), (CH3)4NHB(OAc)3 (3.2 eq), HOAc, DMF, RT, 4 h, 42%.
Pentyl-linked preQ1 dimer 9
To a solution of preQ1 trifluoroacetate (310 mg, 1.06 mmol) in dimethylformamide (5 ml 
Deprotection of oligonucleotides
The solid support was treated each with ammonium hydroxide (28-30%, 0.5 ml) and methylamine in water (40%, 0. 
Purification of RNA
Crude RNA products were purified on a semipreparative Dionex DNAPac PA-100 column (9 mm × 250 mm) at 80°C with flow rate 2 ml/min. Fractions containing RNA were loaded on a 
Determination of ligand binding affinities (KD)
All fluorescence experiments were carried out on a Cary Eclipse spectrometer (Varian, Palo
Alto, USA) equipped with a peltier block, a magnetic stirring device, and a RX2000 stoppedflow apparatus (Applied Photophysics Ltd., Leatherhead, UK). 2-Aminopurine labeled RNA samples (0.5 µM) were prepared in a total volume of 1000 µl of buffer (50 mM MOPS, 100 mM KCl, 2 mM MgCl2, pH 7.5) (4). The samples were heated to 90°C for 2 minutes, allowed to cool to room temperature and held at 20°C in the peltier controlled sample holder in a quartz cuvette equipped with a small stir bar. Then, ligand was manually pipetted in 1μL aliquots in a way not to exceed a total volume increase of 2%. The solution was stirred during each titration step and allowed to equilibrate for at least 10 minutes before data collection. Spectra were recorded from 320 to 500 nm using the following instrumental parameters: excitation wavelength, 308 nm; increments, 1 nm; scan rate, 120 nm/min; slit widths, 10 nm. The apparent binding A1 corresponds to final fluorescence; A2e -k't corresponds to the change in fluorescence over time (t) at the observed rate k'. The measurement for each concentration was repeated at least two times and the mean of the observed rates k' was plotted against ligand concentration to obtain the rate constant k from the slope of the plot. The final rate constant k value is an arithmetic mean, determined from two independent stopped-flow measurements. All data processing was performed using Kaleidagraph software (Synergy Software, Reading, UK). Y corresponds to % inhibition; B corresponds to the bottom plateau of % inhibition; C corresponds to the top plateau of % inhibition; X corresponds to the log of ligand concentration;
Cellular assays (IC50)
HillSlope corresponds to the steepness of the curve; log(IC50) corresponds to the log of the half maximal inhibitory concentration. The final IC50 value was derived from at least two independent measurements. All data processing was performed using GraphPad Prism 5 software (GraphPad Software, La Jolla, USA). Supporting Figure S4 . Stopped-flow fluorescence spectroscopy was used to monitor the kinetics of ligand preQ1 binding to the Spn preQ1 class-II riboswitch. Exemplary real time Ap fluorescence time traces of the Spn A11Ap variant in response to preQ1 1 and preQ1 analogs 3 to 9 (solid line represents single-exponential curve fits); the observed rates kobs were independent of ligand concentrations in the range tested (2 to 14-fold excess of ligand). c(RNA) = 0.3 µM, c(MgCl2) = 2 mM, 100 mM KCl, 50 mM MOPS, pH 7.5, 293 K. Ligand concentration c(ligand) = 1.8 µM.
